| Product Name |
MF |
CAS |
Details |
| N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide |
C21H35NO3 |
249289-10-9 |
|
| Nintedanib Esylate |
C33H39N5O7S |
656247-18-6 |
|
| (R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl methanesulfonate |
C15H19FN2O6S |
174649-09-3 |
|
| Canagliflozin |
C24H25FO5S |
842133-18-0 |
|
| Canagliflozin |
C24H25FO5S |
842133-18-0 |
|
| 2'-O-(2-Methoxyethyl)guanosine |
C13H19N5O6 |
473278-54-5 |
|
| 3-Oxo Ziprasidone (Ziprasidone Impurity B) |
C21H19ClN4O2S |
1159977-56-6 |
|
| Jasmone |
C11H16O |
488-10-8 |
|
| XL147 |
C21H16N6O2S2 |
956958-53-5 |
|
| (2S,3R)-(+)-4-DIMETHYLAMINO-1,2-DIPHENYL-3-METHYL-2-BUTANOL |
C19H25NO |
38345-66-3 |
|
| Dichloro[9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene]palladium(II), |
C39H34Cl2OP2Pd |
205319-10-4 |
|
| 4-Bromophenylacetone |
C9H9BrO |
6186-22-7 |
|
| 1-Bromo-2-Chloro-5-Fluoro-4-Nitrobenzene |
C6H2BrClFNO2 |
1027833-17-5 |
|
| 2-Deoxy-D-glucose |
C6H12O5 |
154-17-6 |
|
| 6-bromocinnolin-4-ol |
C8H5BrN2O |
876-88-0 |
|
| (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol |
C27H41BrO2 |
875573-67-4 |
|
| 5-bromo-2-methoxy-3-(trifluoromethyl)pyridine |
C7H5BrF3NO |
1214377-42-0 |
|
| BMS-754807 |
C23H24FN9O |
1001350-96-4 |
|
| 2-Bromo-4-methylpyridine |
C6H6BrN |
4926-28-7 |
|
| 4-Bromo-2,6-dimethylaniline |
C8H10BrN |
24596-19-8 |
|
| QUERCETIN DIHYDRATE(RG) |
C27H30O17 |
29125-80-2 |
|
| 4-*difluoro(3,4,5-trifluorophenoxy)-methyl]-3,5-difluoro-4'-propyl-1,1'-biphenyl |
C22H15F7O |
303186-20-1 |
|
| TPP-p-NH2-PH2 |
C44H31N5 |
67605-64-5 |
|
| (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide |
C19H14F3N3O3 |
841205-47-8 |
|
| PHOSPHORIC ACI DI-T-BUTYL EXTER CHLOROMETHYL ESTER |
C9H20ClO4P |
229625-50-7 |
|
| PHOSPHORIC ACI DI-T-BUTYL EXTER CHLOROMETHYL ESTER |
C9H20ClO4P |
229625-50-7 |
|
| 1,3,5-Tris(4'-carboxy[1,1'-biphenyl]-4-yl)benzene |
C45H30O6 |
911818-75-2 |
|
| N-[1-[[(Cyanomethyl)amino]carbonyl]cyclohexyl]-4-[2-(4-methyl-1-piperazinyl)-4-thiazolyl]benzamide |
C24H30N6O2S |
294623-49-7 |
|
| TAK-901 |
C28H32N4O3S |
934541-31-8 |
|
| 3-Bromodibenzofuran |
C12H7BrO |
26608-06-0 |
|
| (S)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate |
C24H27ClFN4O6P |
618061-76-0 |
|
| Benzeneethanamine, hydrobromide |
C8H12BrN |
53916-94-2 |
|
| N-Ethyl-p-menthane-3-carboxamide |
C13H25NO |
39711-79-0 |
|
| N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMine |
C14H14ClN5 |
444731-75-3 |
|
| LY 2157299 |
C22H19N5O |
700874-72-2 |
|
| 2-ethenylterephthalic acid |
C10H8O4 |
216431-29-7 |
|
| 4-Bromophenoxybenzene |
C12H9BrO |
101-55-3 |
|
| 5-Oxo-pyrrolidine-3-carboxylic acid amide |
C5H8N2O2 |
14466-21-8 |
|
| L-Homoserine lactone hydrochloride |
C4H8ClNO2 |
2185-03-7 |
|
| Di-t-butyl(3-sulfonatopropyl)phosphine, min. 98% |
C11H25O3PS |
1055888-89-5 |
|
| oxetan-3-yl-acetic acid ethyl ester |
C7H12O3 |
1207175-04-9 |
|
| Pitavastatin Methyl Ester |
C26H26FNO4 |
849811-78-5 |
|
| N-(2-Hydroxyethyl)-2-pyrrolidone |
C6H11NO2 |
3445-11-2 |
|
| 6-HYDROXY-2-NAPHTHALENEBORONIC ACID |
C10H9BO3 |
173194-95-1 |
|
| 3-Formyl-2-nitrobenzoic acid methyl ester |
C9H7NO5 |
138229-59-1 |
|
| Xopenex HFA |
C17H27NO9 |
661464-94-4 |
|
| PF 477736 |
C22H25N7O2 |
952021-60-2 |
|
| Notoginsenoside Ft1 |
C47H80O17 |
155683-00-4 |
|
| Albaspidin AP |
C22H26O8 |
59092-91-0 |
|
| Fmoc-N-Me-Arg(pbf)-OH |
C35H42N4O7S |
913733-27-4 |
|
| (Z)-2-(5-AMino-1,2,4-thiadiazol-3-yl)-2-ethoxyiMinoacetic acid |
C6H8N4O3S |
75028-24-9 |
|
| (4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone |
C24H32N4O5 |
173154-01-3 |
|
| 1-(2-BROMOPHENYL)PIPERAZINE |
C10H13BrN2 |
1011-13-8 |
|
| H2N-PEG4-tBu |
C15H31NO6 |
581065-95-4 |
|
| (Carbomethoxymethyl)triphenylphosphonium bromide |
C21H20BrO2P |
1779-58-4 |
|
| B-(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid |
C24H18BNO2 |
1133058-06-6 |
|
| 6-(2-O-alpha-L-Arabinopyranosyl-beta-D-glucopyranosyl)-2-[4-(beta-D-glucopyranosyloxy)phenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one |
C32H38O19 |
53452-16-7 |
|
| N,N-DIMETHYL-M-PHENYLENEDIAMINE DIHYDROCHLORIDE |
C8H14Cl2N2 |
3575-32-4 |
|
| 5-BroMoquinoline-8-carboxylic acid |
C10H6BrNO2 |
928839-62-7 |
|
| 1-(2,3-dichlorophenyl)-4-(4-hydroxybutyl)piperazine |
C14H20Cl2N2O |
870765-38-1 |
|
| Anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone |
C72H58N2O8 |
112100-07-9 |
|
| (2-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)thiophen-3-yl)Methanol |
C11H17BO3S |
1310384-43-0 |
|
| 1H-INDAZOL-3-YLAMINE |
C7H7N3 |
874-05-5 |
|
| 4-[2-Amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-L-phenylalanine ethyl ester N-benzoylglycine salt |
C36H35ClF3N7O6 |
1137608-69-5 |
|
| Aescin C |
C55H86O24 |
219944-39-5 |
|
| (4R,5S,6S)-4-(Benzoyloxy)-6-[(benzoyloxy)methyl]-5,6-dihydroxy-,2-cyclohexen-1-one |
C21H18O7 |
193410-84-3 |
|
| SENNIDINE B |
C30H18O10 |
517-44-2 |
|
| 6-Bromoquinoxaline |
C8H5BrN2 |
50998-17-9 |
|
| 1-Cyclobutyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
C13H21BN2O2 |
1002309-48-9 |
|
| N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-B]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonaMide |
C23H18ClF2N3O3S |
918504-65-1 |
|
| Ethyl 4,6-dichloro-5-fluoropyridine-3-carboxylate, 2,4-Dichloro-5-(ethoxycarbonyl)-3-fluoropyridine |
C8H6Cl2FNO2 |
154012-17-6 |
|
| DIHYDROFISETIN |
C15H12O6 |
20725-03-5 |
|
| Methyl 2-fluoro-3-methoxybenzoate |
C9H9FO3 |
958991-48-5 |
|
| Rhynchophylline |
C22H28N2O4 |
76-66-4 |
|
| Rhynchophylline |
C22H28N2O4 |
76-66-4 |
|
| 2-(4-Bromophenyl)-5-phenylthiophene |
C16H11BrS |
118621-30-0 |
|
| Fexofenadine hydrochloride |
C32H40ClNO4 |
153439-40-8 |
|
| Fexofenadine hydrochloride |
C32H40ClNO4 |
153439-40-8 |
|
| 2-Methyl-1H-imidazole-4-carbaldehyde |
C5H6N2O |
35034-22-1 |
|
| 9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride |
C30H35ClN4O2 |
1256589-74-8 |
|
| 3,5-DibroMo-biphenyl |
C12H8Br2 |
16372-96-6 |
|
| 5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-ol |
C11H16BNO3 |
1171891-35-2 |
|
| Cycloheptanol |
C7H14O |
502-41-0 |
|
| L-LEUCINE ALLYL ESTER P-TOLUENESULFONATE SALT |
C16H25NO5S |
88224-03-7 |
|
| Pyridoxal phosphate |
C8H10NO6P |
54-47-7 |
|
| 4-Bromo-tetrahydropyran |
C5H9BrO |
25637-16-5 |
|
| NEOHESPERIDOSE |
C12H22O10 |
17074-02-1 |
|
| 5'-Deoxy-5-fluorocytidine |
C9H12FN3O4 |
66335-38-4 |
|
| 5'-Deoxy-5-fluorocytidine |
C9H12FN3O4 |
66335-38-4 |
|
| 5'-Deoxy-5-fluorocytidine |
C9H12FN3O4 |
66335-38-4 |
|
| AvibactaM |
C7H11N3O6S |
1192500-31-4? |
|
| AvibactaM |
C7H11N3O6S |
1192500-31-4 |
|
| 4'-(HEXYLOXY)-4-BIPHENYLCARBONITRILE |
C19H21NO |
41424-11-7 |
|
| 17-Amino-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecanoic acid |
C12H24N2O7 |
1143516-05-5 |
|
| FidaxoMicin |
C52H74Cl2O18 |
873857-62-6 |
|
| Crenolanib |
C26H29N5O2 |
670220-88-9 |
|
| (S)-3-Amino-1-N-Boc-piperidine |
C10H20N2O2 |
625471-18-3 |
|
| 4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]- |
C18H14ClFN4O4 |
314771-88-5 |
|
| Afatinib intermediate C |
C18H14ClFN4O4 |
314771-88-5 |
|
| 2,3,4,5-Tetrahydro-1H-2-benzazepine hydrochloride |
C10H14ClN |
17724-36-6 |
|
